Benign Recurrent Intrahepatic Cholestasis in Pregnancy: Fetal Death at 36 Weeks of Gestation

Introduction Benign recurrent intrahepatic cholestasis is a rare hepatologic disorder characterized by recurrent, self-limited episodes of severe pruritus, jaundice, and elevated bile acids. While there are guidelines for the management of intrahepatic cholestasis of pregnancy, the literature regarding benign recurrent intrahepatic cholestasis and pregnancy is limited. Case A 29-year-old G1P0 woman, with history of liver toxicity, had elevated total serum bile acid levels and liver enzymes documented at 8 weeks of gestation and throughout her pregnancy. She had a reactive nonstress test just 3 days prior to her induction. Fetal demise was noted when she presented at 36 weeks for her induction. Conclusion We recommend that women with elevated total serum bile acid early in pregnancy due to a separate entity relative to intrahepatic cholestasis of pregnancy be managed in a more individualized approach.

[1]  Richard H. Lee,et al.  Society for Maternal-Fetal Medicine (SMFM) Consult Series #53: Intrahepatic Cholestasis of Pregnancy. , 2020, American journal of obstetrics and gynecology.

[2]  N. Terrault,et al.  Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases , 2020, Hepatology.

[3]  T. Kawakita,et al.  Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[4]  I. Boricic,et al.  Intrahepatic Cholestasis of Pregnancy: A Case Study of the Rare Onset in the First Trimester , 2019, Medicina.

[5]  T. Kawakita,et al.  Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses , 2019, The Lancet.

[6]  G. Saade,et al.  Medically-Indicated Late Preterm and Early Term Delivery , 2016 .

[7]  K. Orzechowski,et al.  Severe First Trimester Recurrent Intrahepatic Cholestasis of Pregnancy: A Case Report and Literature Review , 2015, American Journal of Perinatology Reports.

[8]  K. K. Kohli,et al.  Obstetric cholestasis: Outcome with active management , 2013, The journal of obstetrics and gynaecology research.

[9]  N. Tygstrup,et al.  Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. , 2009, Acta medica Scandinavica.

[10]  T. Pusl,et al.  Intrahepatic cholestasis of pregnancy , 2007, Orphanet journal of rare diseases.

[11]  D. Häussinger,et al.  Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. , 2006, Gastroenterology.

[12]  L. Mattsson,et al.  Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates , 2004, Hepatology.

[13]  W. Hansen,et al.  Intrahepatic Cholestasis of Pregnancy: Review of the Literature , 2002, Obstetrical & gynecological survey.

[14]  A. Geubel,et al.  Benign recurrent intrahepatic cholestasis. A report of 26 cases. , 1989, Journal of clinical gastroenterology.

[15]  W. Summerskill,et al.  Benign recurrent intrahepatic "obstructive" jaundice. , 1959, Lancet.

[16]  ACOG Committee Opinion No. 764: Medically Indicated Late-Preterm and Early-Term Deliveries. , 2019, Obstetrics and gynecology.